1. Covaxin, Indias first COVID-19 vaccine candidate, approved for human trial  Geo News
  2. Covid-19: Covaxin is India’s first vaccine to get approval for human clinical trials  Scroll.in
  3. View Full coverage on Google News
Human clinical trials are scheduled to start across the country in July for the COVID-19 vaccineHuman clinical trials are scheduled to start across the country in July for the COVID-19 vaccine

Covaxin, India's first COVID-19 vaccine candidate, approved for human trial

Permission was granted after the firm submitted results from pre-clinical studies of the vaccine that demonstrated its safety and immune response, said Bharat Biotech.Permission was granted after the firm submitted results from pre-clinical studies of the vaccine that demonstrated its safety and immune response, said Bharat Biotech.

Bharat Biotech’s Covid vaccine 1st in India to get approval for human trials | India News,The Indian Express

Indigenous vaccine trials start in JulyIndigenous vaccine trials start in July

DCGI nod for India-made COVID-19 vaccine 'Covaxin' human trials - The Hindu

COVAXIN is an inactivated vaccine which created from a strain of the infectious SARS-CoV-2 virus and has shown promise in preclinical studies, demonstrating extensive safety and effective immune...COVAXIN is an inactivated vaccine which created from a strain of the infectious SARS-CoV-2 virus and has shown promise in preclinical studies, demonstrating extensive safety and effective immune...

COVAXIN: India's First COVID-19 Vaccine Candidate Set For Phase I, II Human Trials

An institute of biological products in Beijing affiliated with the China National Pharmaceutical Group (Sinopharm) announced on Sunday that it had achieved positive results for a COVID-19 vaccine candidate it developed.

Chinese company unveils positive results of COVID-19 vaccines - Global Times

(Reuters) - Bharat Biotech's COVID-19 vaccine has been approved for human trials, making it India's first domestic candidate to get the green light from the government's drug regulator as cases surge in a country with more than 1.3 billion people.(Reuters) - Bharat Biotech's COVID-19 vaccine has been approved for human trials, making it India's first domestic candidate to get the green light from the government's drug regulator as cases surge in a country with more than 1.3 billion people.

India's first COVID-19 vaccine candidate approved for human trials | The Star